✦ LIBER ✦

Evolution of biomarkers of liver fibrosis and liver insufficiency in hepatitis C virus-infected patients treated with pegylated interferon plus ribavirin and rituximab

✍ Scribed by G. Geri; B. Terrier; F. Imbert-Bismut; D. Saadoun; D. Sène; T. Poynard; P. Cacoub

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Chronic Hepatitis C Virus I

✍ B.E. Annicchiarico; M. Siciliano; A.W. Avolio; G. Caracciolo; A. Gasbarrini; S. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Sustained virological response to pegyla

✍ Macías, Juan; Rivero, Antonio; Cifuentes, Celia; Camacho, Angela; Neukam, Karin; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 Spanish ⚖ 283 KB

Treatment of chronic hepatitis C virus i

✍ B.E. Annicchiarico; M. Siciliano; P. Parente; A. Gasbarrini; G. Bombardieri 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Preliminary study of hepatitis C virus R

✍ R. Barcena-Marugan; S. Garcia; G. Moraleda; S. del Campo-Terron; J. Moreno-Garci 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 157 KB

P1184 TREATMENT EFFICACY OF PEGYLATED IN

✍ Shin, S.R.; Park, S.H.; Lee, M.S.; Lee, J.W.; Lee, J.S.; Kim, Y.S.; Choi, M.S.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Therapeutic effects of pegylated interfe

✍ Li-Wei Chen; Rong-Nan Chien; Cho-Li Yen; Jia-Jang Chang; Ching-Jung Liu; Chih-La 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB